These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
485 related items for PubMed ID: 20880116
1. ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. Gelsi-Boyer V, Trouplin V, Roquain J, Adélaïde J, Carbuccia N, Esterni B, Finetti P, Murati A, Arnoulet C, Zerazhi H, Fezoui H, Tadrist Z, Nezri M, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D. Br J Haematol; 2010 Nov; 151(4):365-75. PubMed ID: 20880116 [Abstract] [Full Text] [Related]
2. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia. Pérez B, Kosmider O, Cassinat B, Renneville A, Lachenaud J, Kaltenbach S, Bertrand Y, Baruchel A, Chomienne C, Fontenay M, Preudhomme C, Cavé H. Br J Haematol; 2010 Dec; 151(5):460-8. PubMed ID: 20955399 [Abstract] [Full Text] [Related]
3. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Gelsi-Boyer V, Trouplin V, Adélaïde J, Bonansea J, Cervera N, Carbuccia N, Lagarde A, Prebet T, Nezri M, Sainty D, Olschwang S, Xerri L, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D. Br J Haematol; 2009 Jun; 145(6):788-800. PubMed ID: 19388938 [Abstract] [Full Text] [Related]
4. Prognostic score including gene mutations in chronic myelomonocytic leukemia. Itzykson R, Kosmider O, Renneville A, Gelsi-Boyer V, Meggendorfer M, Morabito M, Berthon C, Adès L, Fenaux P, Beyne-Rauzy O, Vey N, Braun T, Haferlach T, Dreyfus F, Cross NC, Preudhomme C, Bernard OA, Fontenay M, Vainchenker W, Schnittger S, Birnbaum D, Droin N, Solary E. J Clin Oncol; 2013 Jul 01; 31(19):2428-36. PubMed ID: 23690417 [Abstract] [Full Text] [Related]
13. Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis. Lin Y, Zheng Y, Wang ZC, Wang SY. Hematology; 2016 Sep 01; 21(8):454-61. PubMed ID: 27077763 [Abstract] [Full Text] [Related]
19. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia. Invernizzi R, Travaglino E, Benatti C, Malcovati L, Della Porta M, Cazzola M, Ascari E. Eur J Haematol; 2006 Jun 16; 76(6):494-501. PubMed ID: 16529600 [Abstract] [Full Text] [Related]
20. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center]. Qu SQ, Pan LJ, Qin TJ, Xu ZF, Li B, Wang HJ, Sun Q, Jia YJ, Li CW, Cai WY, Gao QY, Jiao M, Xiao ZJ. Zhonghua Xue Ye Xue Za Zhi; 2023 May 14; 44(5):373-379. PubMed ID: 37550186 [Abstract] [Full Text] [Related] Page: [Next] [New Search]